AdaptHealth Corp. (AHCO) vs Avalo Therapeutics, Inc. (AVTX)
A side-by-side comparison of AdaptHealth Corp. and Avalo Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AHCO
AdaptHealth Corp.
$5.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
AVTX
Avalo Therapeutics, Inc.
$13.59HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AHCO vs AVTX
growth of $100 · dividends reinvested · last 8yAHCO -40.8% (-6.3%/yr)AVTX -99.9% (-56.5%/yr)AHCO compounded faster over this window
Log scale — wide-divergence pair
AHCO AVTX
AHCO vs AVTX: by the numbers
- •AHCO is the larger company ($785M vs $714M market cap).
- •Both run net losses; AHCO's is the smaller (-7.58% vs -170055.93% net margin).
- •AHCO grew revenue faster over the past five years (11.68% vs -60.88% CAGR).
Metrics side by side
Valuation
| Metric | AHCO | AVTX |
|---|---|---|
| P/S ratio | 0.26 | 12107.91 |
| P/B ratio | 0.57 | 1.59 |
| EV / EBITDA | 6.63 | N/A |
| FCF yield | 12.44% | N/A |
Profitability
| Metric | AHCO | AVTX |
|---|---|---|
| Gross margin | 10.37% | 100.00% |
| Operating margin | -0.31% | -123601.69% |
| Net margin | -7.58% | -170055.93% |
| ROE | -16.56% | -22.36% |
| ROIC | -0.26% | -19.45% |
Growth (annualized)
| Metric | AHCO | AVTX |
|---|---|---|
| Revenue CAGR (5Y) | 11.68% | -60.88% |
| FCF CAGR (5Y) | 7.07% | N/A |
| Total return CAGR (5Y) | -24.65% | -70.04% |
Frequently asked
- Which has grown faster, AHCO or AVTX?
- Over the past five years, AHCO grew revenue faster — AHCO at a 11.68% CAGR versus AVTX at -60.88%.
- How have AHCO and AVTX total returns compared?
- Over the past 5 years, AHCO delivered -24.65% and AVTX delivered -70.04% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AdaptHealth ROEAvalo Therapeutics ROEAdaptHealth operating marginAvalo Therapeutics operating marginAdaptHealth revenue growthAvalo Therapeutics revenue growthAdaptHealth free cash flowAvalo Therapeutics free cash flow
AdaptHealth & Avalo Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.